These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1113 related items for PubMed ID: 28844951

  • 1. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK, Karlsen TH, Folseraas T.
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
    Pinto C, Giordano DM, Maroni L, Marzioni M.
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
    [Abstract] [Full Text] [Related]

  • 4. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
    Rupp C, Bode KA, Leopold Y, Sauer P, Gotthardt DN.
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
    [Abstract] [Full Text] [Related]

  • 5. Bile acid receptors in the biliary tree: TGR5 in physiology and disease.
    Deutschmann K, Reich M, Klindt C, Dröge C, Spomer L, Häussinger D, Keitel V.
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1319-1325. PubMed ID: 28844960
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Drug-induced bile duct injury.
    Visentin M, Lenggenhager D, Gai Z, Kullak-Ublick GA.
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
    [Abstract] [Full Text] [Related]

  • 8. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Timmer MR, Beuers U, Fockens P, Ponsioen CY, Rauws EA, Wang KK, Krishnadath KK.
    Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
    Taghavi SA, Eshraghian A, Niknam R, Sivandzadeh GR, Bagheri Lankarani K.
    Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):575-584. PubMed ID: 29781738
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of cholangiocyte responses to injury.
    Sato K, Meng F, Giang T, Glaser S, Alpini G.
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1262-1269. PubMed ID: 28648950
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. How the biliary tree maintains immune tolerance?
    Zhang H, Leung PSC, Gershwin ME, Ma X.
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1367-1373. PubMed ID: 28844953
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis.
    Kawata K, Kobayashi Y, Gershwin ME, Bowlus CL.
    Clin Rev Allergy Immunol; 2012 Dec; 43(3):230-41. PubMed ID: 22689287
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB, Jacobson IM.
    Rev Gastroenterol Disord; 2009 Dec; 9(2):E41-7. PubMed ID: 19668124
    [Abstract] [Full Text] [Related]

  • 18. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
    Boyd S, Vannas M, Jokelainen K, Isoniemi H, Mäkisalo H, Färkkilä MA, Arola J.
    World J Gastroenterol; 2017 Sep 07; 23(33):6147-6154. PubMed ID: 28970730
    [Abstract] [Full Text] [Related]

  • 19. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
    Lapitz A, Azkargorta M, Milkiewicz P, Olaizola P, Zhuravleva E, Grimsrud MM, Schramm C, Arbelaiz A, O'Rourke CJ, La Casta A, Milkiewicz M, Pastor T, Vesterhus M, Jimenez-Agüero R, Dill MT, Lamarca A, Valle JW, Macias RIR, Izquierdo-Sanchez L, Pérez Castaño Y, Caballero-Camino FJ, Riaño I, Krawczyk M, Ibarra C, Bustamante J, Nova-Camacho LM, Falcon-Perez JM, Elortza F, Perugorria MJ, Andersen JB, Bujanda L, Karlsen TH, Folseraas T, Rodrigues PM, Banales JM.
    J Hepatol; 2023 Jul 07; 79(1):93-108. PubMed ID: 36868481
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.